| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d0446a5bd77c7da68216fc2e3f05d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff00c9b919a7efd7f7df2ea02ed6b0ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_766eae8ff319d5744cdadf9b32cf8baa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc6c1c127a532d10523a3c348c88edc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a3695fb9cf80bf169aa00805bd15d29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dabb03d929dd233901a16278af6b7a06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5a48e4efe95087a1b56f7410202e85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16daff80d093d214b370a13bf4121b74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7bb5e78afcb6266e6d2b4611f2266a0 |
| publicationDate |
2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2272537-A2 |
| titleOfInvention |
Salts of conjugated psychotropic drugs and processes of preparing same |
| abstract |
Novel chemical conjugates of a psychotropic drug residue and an amino-containing organic acid residue selected to reduce side effects induced by the psychotropic drug when administered per se, to enhance the therapeutic activity of the psychotropic drug and/or to exert anti-proliferative activity, in which the amino group is in the form of an acid addition salt thereof and which are characterized by high stability are disclosed. Further disclosed are processes for preparing the chemical conjugates and addition salts thereof, pharmaceutical compositions containing the chemical conjugates and methods utilizing the chemical conjugates for treating various medical conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722923-B2 |
| priorityDate |
2005-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |